Computational Analysis on The Drug Target Pathways
Parallel to all ongoing trials and formulation development, our scientific in silico teams we’re conducting close to 400 individual molecular docking analysis on all described drug target pathways.
Please see below chart with all the detailed docking scores of our bio active molecules and the subsequent virus/host cell interactions.
Vedicinals® 9 efficacy against Mutants
Every time new genomic sequencing information is published, our in silico scientific team started to verify that our bio active molecules are still working against the newly occurring strains.
Our past evaluations surprisingly documented better binding affinities toward the mutated virus proteases than the previous wild type SARS-COV-2 variants.
Below is Detailed Report